Anne Wojcicki, co-founder and CEO of 23andMe, talks about how ethical concerns over genetic research sometimes stem from science fiction. She uses the example of recent breakthroughs in gene editing, and how, despite existing knowledge about genetic disorders, we still can’t use innovations like “CRISPR” to cure them. That, Wojcicki says, fuels her passion to completely understand the human genome.
Related
![Photo of Alexandra Zatarain](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/05/Alexandra-Zatarain-600x600-1.png)
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Video
50 minutes
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
![Photo of Maria Barrera](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/04/Maria-Barrera-600x600-.png)
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Video
49 minutes
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
![Photo of David Allemann](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/03/David-Allemann-600x600-2.png)
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
Video
50 minutes
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.